Cargando…
Macrophages in metabolic associated fatty liver disease
Metabolic associated fatty liver disease (MAFLD), formerly named non-alcoholic fatty liver disease is the most common liver disorder in many countries. The inflammatory subtype termed steatohepatitis is a driver of disease progression to cirrhosis, hepatocellular carcinoma, liver transplantation, an...
Autores principales: | Alharthi, Jawaher, Latchoumanin, Olivier, George, Jacob, Eslam, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201150/ https://www.ncbi.nlm.nih.gov/pubmed/32390698 http://dx.doi.org/10.3748/wjg.v26.i16.1861 |
Ejemplares similares
-
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022) -
A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
por: Alharthi, Jawaher, et al.
Publicado: (2022) -
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
por: Metwally, Mayada, et al.
Publicado: (2021) -
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
por: Huo, Xiaoqi, et al.
Publicado: (2017) -
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)